41 – 50 of 141
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Proteoglycans : a common portal for SARS-CoV-2 and extracellular vesicle uptake
- Contribution to journal › Scientific review
-
Mark
Occupational risk of COVID-19 related hospital admission in Denmark 2020–2021 : a follow-up study
- Contribution to journal › Article
-
Mark
Frequent use of IGHV3-30-3 in SARS-CoV-2 neutralizing antibody responses
- Contribution to journal › Article
-
Mark
High titers of neutralizing SARS-CoV-2 antibodies six months after symptom onset are associated with increased severity in COVID-19 hospitalized patients
- Contribution to journal › Article
-
Mark
Detoxified synthetic bacterial membrane vesicles as a vaccine platform against bacteria and SARS-CoV-2
- Contribution to journal › Article
- 2022
-
Mark
Molecular and Serologic Diagnostic Technologies for SARS-CoV-2
(2022) In arXiv.org
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Clinically observed deletions in SARS-CoV-2 Nsp1 affect its stability and ability to inhibit translation
- Contribution to journal › Article
-
Mark
Can They Stay or Will They Go? : A Cross Sectional Study of Managers' Attitudes towards Their Senior Employees
- Contribution to journal › Article
-
Mark
Functional Antibodies Against SARS-CoV-2 Receptor Binding Domain Variants with Mutations N501Y or E484K in Human Milk from COVID-19-Vaccinated, -Recovered, and -Unvaccinated Women
- Contribution to journal › Article
-
Mark
Spike-Dependent Opsonization Indicates Both Dose-Dependent Inhibition of Phagocytosis and That Non-Neutralizing Antibodies Can Confer Protection to SARS-CoV-2
- Contribution to journal › Article
